A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer

被引：0
|
作者：
Adams, M
Mort, D
Coleman, R
Wiliams, L
Evans, A
Thompson, M
机构：
[1] VELINDRE HOSP NHS TRUST,CARDIFF,S GLAM,WALES
[2] WESTON PK HOSP TRUST,SHEFFIELD,S YORKSHIRE,ENGLAND
[3] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,HOUNSLOW,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [41] Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO
    Sehouli, Jalid
    Stengel, Dirk
    Mustea, Alexander
    Camara, Oumar
    Keil, Elke
    Elling, Dirk
    Ledwon, Peter
    Christiansen, Bernd
    Klare, Peter
    Gebauer, Gerhard
    Schwarz, Marina
    Lichtenegger, Werner
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 243 - 250
  • [42] A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma
    De Vos, FYFL
    Bos, AME
    Schaapveld, M
    de Swart, CAM
    de Graaf, H
    van der Zee, AGJ
    Boezen, HM
    de Vries, EGE
    Willemse, PHB
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 60 - 67
  • [43] CARBOPLATIN IN COMBINATION WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A PHASE-II STUDY
    ANDERSSON, H
    FRIBERG, LG
    HORVATH, G
    JOHANSSON, O
    AKESSON, M
    WESTBERG, R
    ACTA ONCOLOGICA, 1995, 34 (06) : 821 - 827
  • [44] Paclitaxel as salvage therapy in advanced pretreated ovarian cancer: A phase II study
    Nardi, M
    Aloe, A
    DeMarco, S
    Cognetti, F
    Iacovelli, A
    Atlante, G
    Calabresi, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (03): : 230 - 232
  • [45] Paclitaxel plus ifosfamide in advanced ovarian cancer - A multicenter phase II study
    Miglietta, L
    Amoroso, D
    Bruzzone, M
    Granetto, C
    Catsafados, E
    Mammoliti, S
    Guarneri, D
    Pedulla, F
    Foglia, G
    Ragni, N
    Martini, MC
    Brema, F
    Addamo, G
    Moraglio, L
    Pastorino, G
    Boccardo, F
    ONCOLOGY, 1997, 54 (02) : 102 - 107
  • [46] Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
    De Lena, M
    Lorusso, V
    Latorre, A
    Fanizza, G
    Gargano, G
    Caporusso, L
    Guida, M
    Catino, A
    Crucitta, E
    Sambiasi, D
    Mazzei, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 364 - 368
  • [47] Paclitaxel-cisplatin combination in advanced ovarian cancer: A phase II study
    Sugiyama T.
    Yakushiji M.
    Aoki Y.
    Tanaka K.
    Nishimura R.
    Hasegawa K.
    Ikeda M.
    Noda K.
    International Journal of Clinical Oncology, 2000, 5 (2) : 85 - 88
  • [48] Carboplatin plus paclitaxel scheduling for advanced ovarian cancer
    Baratti, Dario
    Kusamura, Shigeki
    Deraco, Marcello
    LANCET ONCOLOGY, 2014, 15 (07): : E249 - E249
  • [49] Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancer
    Neijt, JP
    du Bois, A
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 78 - 83
  • [50] Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin-Topotecan and Carboplatin-Paclitaxel vs Carboplatin-Paclitaxel
    Hoskins, P.
    Vergote, I.
    Cervantes, A.
    Tu, D.
    Stuart, G.
    Zola, P.
    Poveda, A.
    Provencher, D.
    Katsaros, D.
    Ojeda, B.
    Ghatage, P.
    Grimshaw, R.
    Casado, A.
    Elit, L.
    Mendiola, C.
    Sugimoto, A.
    D'Hondt, V.
    Oza, A.
    Germa, J. R.
    Roy, M.
    Brotto, L.
    Chen, D.
    Eisenhauer, E. A.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (20) : 1547 - 1556
12345